Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,579 | 196 | 98.7% |
| Education | $61.25 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $604.16 | 26 | $0 (2024) |
| PFIZER INC. | $389.66 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $343.45 | 14 | $0 (2021) |
| Amarin Pharma Inc. | $342.64 | 8 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $331.02 | 15 | $0 (2024) |
| Lilly USA, LLC | $293.23 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $290.61 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $265.73 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $244.43 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $236.92 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.21 | 35 | Novo Nordisk Inc ($236.89) |
| 2023 | $379.88 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($87.02) |
| 2022 | $523.11 | 17 | E.R. Squibb & Sons, L.L.C. ($133.38) |
| 2021 | $369.86 | 18 | PFIZER INC. ($139.91) |
| 2020 | $255.74 | 13 | Janssen Pharmaceuticals, Inc ($83.21) |
| 2019 | $910.49 | 39 | Amarin Pharma Inc. ($267.23) |
| 2018 | $1,201 | 51 | SANOFI-AVENTIS U.S. LLC ($244.43) |
| 2017 | $269.85 | 8 | Regeneron Healthcare Solutions, Inc. ($125.00) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Gastroenterology | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Gastroenterology | ||||||
| 08/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Obesity | ||||||
| 07/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,101 | 1,394 | $460,822 | $142,116 |
| 2022 | 9 | 912 | 1,189 | $383,298 | $114,410 |
| 2021 | 8 | 788 | 1,102 | $331,582 | $99,718 |
| 2020 | 9 | 732 | 973 | $281,167 | $69,735 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 199 | 199 | $120,391 | $37,090 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 338 | $129,437 | $36,785 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 283 | 413 | $108,462 | $32,095 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $63,373 | $22,449 | 35.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $9,754 | $3,715 | 38.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $9,353 | $2,988 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $9,324 | $2,264 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $2,950 | $2,070 | 70.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 17 | $2,550 | $1,309 | 51.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 59 | 71 | $4,671 | $839.16 | 18.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 62 | $558.00 | $512.40 | 91.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 506 | $193,773 | $54,104 | 27.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 149 | 149 | $90,142 | $28,568 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 290 | $76,160 | $22,907 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $7,407 | $2,696 | 36.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 33 | 33 | $5,180 | $2,262 | 43.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 22 | $3,300 | $1,434 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $2,050 | $1,417 | 69.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 61 | 65 | $4,701 | $828.67 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 65 | $585.00 | $192.75 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 386 | 599 | $229,387 | $68,755 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 195 | 277 | $72,746 | $22,447 | 30.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $16,316 | $4,225 | 25.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 22 | 22 | $4,500 | $1,461 | 32.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 14 | $2,100 | $1,125 | 53.6% |
About Dr. Laszlo Feher, DO
Dr. Laszlo Feher, DO is a Geriatric Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205932290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laszlo Feher, DO has received a total of $4,640 in payments from pharmaceutical and medical device companies, with $730.21 received in 2024. These payments were reported across 198 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,579).
As a Medicare-enrolled provider, Feher has provided services to 3,533 Medicare beneficiaries, totaling 4,658 services with total Medicare billing of $425,980. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location New York, NY
- Active Since 09/16/2006
- Last Updated 08/26/2019
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205932290
Products in Payments
- ELIQUIS (Drug) $442.51
- Ozempic (Drug) $395.69
- Vascepa (Drug) $342.64
- PRALUENT (Drug) $244.43
- XARELTO (Drug) $234.66
- JARDIANCE (Drug) $217.21
- XIFAXAN (Drug) $212.19
- MYRBETRIQ (Drug) $175.36
- TRELEGY ELLIPTA (Drug) $165.75
- Rybelsus (Drug) $146.69
- TRULICITY (Drug) $137.81
- CHANTIX (Drug) $129.09
- PRALUENT ALIROCUMAB INJECTION (Biological) $125.00
- INVOKANA (Drug) $108.79
- MOUNJARO (Drug) $108.74
- JANUVIA (Drug) $82.92
- Synthroid (Drug) $81.16
- WELLBUTRIN (Drug) $72.02
- APLENZIN (Drug) $71.42
- SYNTHROID (Drug) $68.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in New York
Dr. Howard Fillit, Md, MD
Geriatric Medicine — Payments: $64,263
Lisa Babitz, Md, MD
Geriatric Medicine — Payments: $7,071
Dr. Kenneth Mercer, Md Mph, MD MPH
Geriatric Medicine — Payments: $4,806
Laleh Moazen, M.d, M.D
Geriatric Medicine — Payments: $4,667
John Getsos, M.d, M.D
Geriatric Medicine — Payments: $3,449
Dr. Eric Manheimer, Md, MD
Geriatric Medicine — Payments: $3,396